Literature DB >> 15952798

Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2).

Antara Banerjee1, Abhijit Ray, Cheng Chang, Peter W Swaan.   

Abstract

The residues involved in substrate interaction of the human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) remain undefined. Biochemical modification of conserved cysteine residues has suggested their direct involvement in hASBT function. In the present study, we developed novel methanethiosulfonyl (MTS)-bile salt derivatives and describe their reactivity toward hASBT and its mutants. Endogenous Cys residues were subjected to Ala/Thr scanning mutagenesis and subsequent exposure to affinity inactivators. We show that C51A/T, C105A/T, C144A, and C255A/T are loss-of-function mutations. Additionally, C74A/T cell surface expression was abolished suggesting a role in protein folding and/or trafficking. C270A remained largely unaffected in the presence of 1.0 mM polar and charged MTS reagents (MTSEA, MTSES, and MTSET) and retained function similar to wt-hASBT control. However, in the presence of synthetic cholyl- and chenodeoxycholyl-MTS analogues, C270A displayed a significant decrease in K(T) and J(max). Our findings demonstrate that Cys270 is a highly accessible extracellular residue susceptible to thiol modification in its native form that remains largely unaffected upon mutation to Ala. Consequently, C270A provides an ideal scaffold for cysteine scanning mutagenesis studies. Furthermore, the substantial decrease in ligand affinity and maximal transport capacity of C270A suggest that C270 may potentially impact, although not critically, a putative substrate binding domain of hASBT. Overall, bile acid-MTS conjugates can serve as novel and powerful tools to probe the role of endogenous as well as engineered Cys residues and, ultimately, aid in defining their role in the bile acid binding region(s) of hASBT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952798     DOI: 10.1021/bi050553s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains.

Authors:  Antara Banerjee; Peter W Swaan
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

3.  Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2.

Authors:  Tatiana Claro da Silva; Naissan Hussainzada; Chandra M Khantwal; James E Polli; Peter W Swaan
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

4.  Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).

Authors:  Richard H Ho; Brenda F Leake; Brad L Urquhart; Jamie C Gregor; Paul A Dawson; Richard B Kim
Journal:  J Gastroenterol Hepatol       Date:  2011-12       Impact factor: 4.029

Review 5.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

6.  Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.

Authors:  Hairat Sabit; Sairam S Mallajosyula; Alexander D MacKerell; Peter W Swaan
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

Review 7.  The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.

Authors:  J Geyer; T Wilke; E Petzinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-16       Impact factor: 3.000

Review 8.  Exploitation of bile acid transport systems in prodrug design.

Authors:  Elina Sievänen
Journal:  Molecules       Date:  2007-08-16       Impact factor: 4.411

9.  The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Peter W Swaan
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

10.  Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.

Authors:  Robyn H Moore; Paresh Chothe; Peter W Swaan
Journal:  Biochemistry       Date:  2013-07-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.